← Back to Search

Platelet Rich Plasma

Sample group 4 for Osteoarthritis

Phase 2
Waitlist Available
Led By Leon Scott, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 12 weeks, 26 weeks post injections
Awards & highlights

Study Summary

This trial is testing whether different doses of platelet-rich plasma injections can improve knee pain in patients.

Eligible Conditions
  • Osteoarthritis of the Knee

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 12 weeks, 26 weeks post injections
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 12 weeks, 26 weeks post injections for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Western Ontario and McMaster University's Osteoarthritis Index (WOMAC)
Secondary outcome measures
Visual Analog Scale (VAS)

Trial Design

5Treatment groups
Active Control
Placebo Group
Group I: Sample group 4Active Control1 Intervention
Sample of subjects with primary osteoarthritis of the knee
Group II: Sample group 2Active Control1 Intervention
Sample of subjects with primary osteoarthritis of the knee
Group III: Sample group 1Active Control1 Intervention
Sample of subjects with primary osteoarthritis of the knee
Group IV: Sample group 3Active Control1 Intervention
Sample of subjects with primary osteoarthritis of the knee
Group V: Sample group 5Placebo Group1 Intervention
Sample of subjects with primary osteoarthritis of the knee

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
857 Previous Clinical Trials
672,197 Total Patients Enrolled
4 Trials studying Osteoarthritis
612 Patients Enrolled for Osteoarthritis
Leon Scott, MDPrincipal InvestigatorVanderbilt University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently being enrolled in this trial?

"This particular study, as denoted by clinicaltrials.gov, is not currently looking for participants. This trial was originally posted on January 1st 2023 but the most recent edit occurred on August 12th, 2022. Although this study isn't ongoing, there are 727 other trials that patients can participate in."

Answered by AI

What is the FDA's current stance on Sample group 2?

"While there is data supporting the safety of Sample group 2, there is currently no evidence for it being an effective treatment. As such, it received a score of 2."

Answered by AI

To whom is this trial open?

"Osteoarthritis sufferers that are aged 40 to 80 and have knee pain may be eligible for this study. Currently, the trial is looking to enroll 190 total patients."

Answered by AI

Does this clinical trial have an age limit? If so, what is the cutoff for patients?

"The age limit for this clinical trial is 80 years old. Anybody above the age of 40 can apply to be a participant."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
How Does Platelet Dose Impact Clinical Outcomes After PRP Treatment?
Leon Scott 2022. "How Does Platelet Dose Impact Clinical Outcomes After PRP Treatment?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05330689.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top